Try GOLD - Free
Your fancy, new ETF might be a little too fancy
Mint Kolkata
|January 08, 2025
Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good
History teaches that financial complexity always creeps upward. Lately that trend has reached investor-friendly exchange-traded funds.
Last year, U.S.-based ETFs broke a record, surpassing $1 trillion in total inflows. They are cheap, liquid and, crucially, far more tax-efficient than traditional mutual funds.
If you want to hold stocks and bonds, the flagship trackers from industry giants BlackRock, Vanguard and State Street Global Advisors already do the trick for very low fees. It is tough, and not especially rewarding, to compete with those industry behemoths head-on.
So Wall Street has found a new gold rush: packaging even more sophisticated products in ETF form.
About 30% of ETFs launched in the U.S. in 2024 referred to some complex strategy in their names, an analysis of Morningstar Direct data suggests—double the average of the previous nine years. What it says on the label is becoming increasingly creative, and what happens inside of those funds is increasingly obscure.
That complexity sometimes delivers a poor return compared with the plain vanilla variety. After a dismal December, the Simplify Enhanced Income ETF—trading under the ticker HIGH—ended 2024 with a total return of 1.5%, despite its prospectus saying that "it seeks to provide significant supplemental income to T-bills." The SPDR Bloomberg 1-3 Month T-Bill ETF, or BIL, returned 5.2%.
This story is from the January 08, 2025 edition of Mint Kolkata.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Kolkata
Mint Kolkata
When LLMs learn to take shortcuts, they become evil
Some helpful parenting tips: it is very easy to accidentally teach your children lessons you did not intend to pass on.
2 mins
November 28, 2025
Mint Kolkata
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Kolkata
Would you like to be interviewed by an AI bot instead?
don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.
3 mins
November 28, 2025
Mint Kolkata
Can I claim TDS refund despite missing return filing deadline?
I am an NRI living in Dubai and have investments in Indian listed stocks. One of the companies I invested in, did a buyback in March, on which Tax Deducted at Source (TDS) was deducted. At that time, I was advised by a friend that I could claim a refund of TDS at the time of filing my tax return due to the benefits of the Double Taxation Avoidance Agreement (DTAA).
2 mins
November 28, 2025
Mint Kolkata
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Mint Kolkata
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Kolkata
Refiners, SCI tap Korean giants for local shipyard
Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions
2 mins
November 28, 2025
Mint Kolkata
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
1 mins
November 28, 2025
Mint Kolkata
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Kolkata
What if China weaponizes its dominance of pharma inputs?
Overdependence on China for drug-making should worry the US
3 mins
November 28, 2025
Listen
Translate
Change font size

